These findings not only deepen our understanding of the mechanisms underlying lupus-associated pain, but also suggest that targeting TLR7 or its downstream effectors may represent a promising strategy to alleviate chronic pain associated with SLE. This evidence concerns the gene TLR7 and systemic lupus erythematosus.